Nanyang Biologics Joins NVIDIA GTC 2025: Advancing AI in Drug Discovery

Nanyang Biologics is revolutionizing drug discovery with AI at NVIDIA GTC 2025! Discover how we’re using the latest technologies to accelerate life-saving innovations.

‍

The future of drug discovery is being rewritten by AI, and Nanyang Biologics is leading the charge. We’re thrilled to announce our participation in NVIDIA GTC 2025, the premier global AI conference, taking place from March 16 - 21, 2025 in San Jose, CA. This global conference brings together industry leaders, researchers, and innovators to explore the future of AI-powered innovation. This is where Nanyang Biologics will showcase how we’re revolutionizing drug discovery, turning cutting-edge science into life-saving solutions. Ready to see the future unfold? Let’s dive in!

NVIDIA GTC 2025: The AI Event of the Year

‍

Hosted by NVIDIA, GTC 2025 is the most anticipated AI conference, bringing together researchers, developers, and business leaders to explore the latest advancements in AI, high-performance computing (HPC), and deep learning. From healthcare and biotechnology to robotics and autonomous systems, GTC provides an unparalleled platform for thought leadership, collaboration, and technological breakthroughs.

‍

GTC25 is where Nanyang Biologics will showcase our dedication to pushing the boundaries of AI and biotechnology, solving some of the most pressing challenges in healthcare. By sharing our innovations on this global stage, we’re not just inspiring collaboration with industry leaders, researchers, and investors, we’re driving the adoption of AI-powered solutions that could change lives.

‍

NYB’s Key Highlights at GTC 2025

‍

At NVIDIA GTC 2025, Nanyang Biologics will take the stage with two exciting contributions that highlight our leadership in AI-driven drug discovery:

‍

Poster Presentation: “Effective Drug Discovery by Predicting Bioactivities Using Graph Neural Network and Self-Attention”

‍

📅 March 16 - 20, 2025

Dive into the future of drug discovery with our poster presentation, where we unveil how Graph Neural Networks (GNNs) and self-attention mechanisms are transforming the way we predict compound bioactivity. This isn’t just science - it’s a faster, smarter, and more efficient way to identify life-saving drug candidates. Join us to see how AI is reshaping the pharmaceutical landscape.

‍

Startup Pitch: “Nanyang Biologics: Accelerating Molecule Screening with Graph Neural Networks”

‍

📅 March 20, 2025

Get ready for a glimpse into the future of molecule screening. In our startup pitch, we’ll reveal how our proprietary AI platform DTIGN is streamlining pharmaceutical R&D for top executives, research directors, and data scientists. By dramatically reducing both the time and cost of drug discovery with exceptional precision, DTIGN is paving the way for faster development of life-changing treatments.

‍

Exhibition Booth with Equinix

‍

📅 March 19 - 20, 2025

In partnership with Equinix, NYB will be presenting an interactive booth, featuring live demonstrations and expert discussions on next-generation molecular screening technologies powered by AI.

‍

Shaping the Future of AI in Drug Discovery

‍

“Our participation in NVIDIA GTC 2025 marks a significant milestone for NYB. As an Equinix partner, we are excited to demonstrate how AI-driven compound screening can revolutionize drug discovery, leading to faster and more effective treatments” said Giang Nguyen, CTO at NYB. “This event is an opportunity to connect with global leaders in AI and pharma, fostering meaningful collaborations.” 

‍

Join Us at GTC 2025!

‍

The future of AI-driven drug discovery is here, and Nanyang Biologics is at the heart of it. Don’t miss your chance to be part of this transformative journey! Whether you’re attending in person or virtually, join us at NVIDIA GTC 2025 to explore how we’re shaping the future of healthcare.

‍

Stay tuned for updates on our presentations and follow us on social media for live coverage from the event!

‍